New hope for advanced breast cancer patients after standard treatments fail
NCT ID NCT04802759
Summary
This study is testing several new combinations of drugs for people with advanced breast cancer that has stopped responding to standard hormone therapies. It aims to find better ways to control the disease and extend life. The trial is enrolling about 316 participants with specific types of breast cancer that have spread or cannot be surgically removed. It is designed to be flexible, allowing researchers to add promising new treatments or stop less effective ones as the study progresses.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INOPERABLE, LOCALLY ADVANCED OR METASTATIC, ER-POSITIVE BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Asan Medical Center
RECRUITINGSeoul, 05505, South Korea
-
Assuta Medical Centers
RECRUITINGTel Aviv, 6971028, Israel
-
Centro Integral Oncológico Clara Campal Ensayos Clínicos START
RECRUITINGMadrid, 28050, Spain
-
City of Hope
RECRUITINGDuarte, California, 91010, United States
-
Flinders Medical Centre
RECRUITINGBedford Park, South Australia, 5042, Australia
-
Hadassah Ein Karem Hospital
RECRUITINGJerusalem, 91120, Israel
-
Hospital Clinico Universitario de Valencia
RECRUITINGValencia, 46010, Spain
-
Hospital Universitario Ramón y Cajal
RECRUITINGMadrid, 28034, Spain
-
Hospital Universitario Vall d Hebron
RECRUITINGBarcelona, 08035, Spain
-
Levine Cancer Institute
RECRUITINGCharlotte, North Carolina, 28204, United States
-
Linear Clinical Research Limited
RECRUITINGNedlands, Western Australia, 6009, Australia
-
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
RECRUITINGSanta Monica, California, 90404, United States
-
Massachusetts General Hospital
RECRUITINGBoston, Massachusetts, 02114, United States
-
National Cancer Center
RECRUITINGGoyang-si, 10408, South Korea
-
Peninsula Health-Frankston Hospital
RECRUITINGFrankston, Victoria, 3199, Australia
-
Peter Maccallum Cancer Centre
RECRUITINGMelbourne, Victoria, 3000, Australia
-
Rabin MC
RECRUITINGPetah Tikva, 4941492, Israel
-
Rambam Medical Center
RECRUITINGHaifa, 3109601, Israel
-
Regional Cancer Care Associates LLC (RCCA) - Freehold Location
WITHDRAWNFreehold, New Jersey, 07728, United States
-
Regional Cancer Care Associates LLC ? Howell Division
WITHDRAWNHowell Township, New Jersey, 07731, United States
-
Samsung Medical Center
RECRUITINGSeoul, (0)6351, South Korea
-
Seoul National University Hospital
RECRUITINGSeoul, 03080, South Korea
-
Severance Hospital
RECRUITINGSeoul, 3722, South Korea
-
Shaare Zedek Medical Center
RECRUITINGJerusalem, Jerusalem, 9103102, Israel
-
Stanford Cancer Institute (SCI)
RECRUITINGStanford, California, 94305, United States
-
Tel Aviv Sourasky Medical Center
RECRUITINGTel Aviv, 6423906, Israel
-
The Chaim Sheba Medical Center
RECRUITINGRamat Gan, 52621, Israel
-
Thomas Jefferson University Hospital
RECRUITINGPhiladelphia, Pennsylvania, 19107, United States
-
University of California, San Francisco (UCSF)
RECRUITINGSan Francisco, California, 94143, United States
-
University of Pittsburgh Cancer Institute
WITHDRAWNPittsburgh, Pennsylvania, 15219, United States
-
West Cancer Center
RECRUITINGGermantown, Tennessee, 38138, United States
Conditions
Explore the condition pages connected to this study.